NON-NATIVE POLYMERASE ENCODING NUCLEIC ACID CONSTRUCT
First Claim
1. A non-naturally occurring construct which when present in a cell produces a product, said construct comprising at least one modified nucleotide, a nucleotide analog or a non-nucleic acid entity, or a combination of the foregoing.
6 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides an array of compositions useful for effecting and/or exhibiting changes in biological functioning and processing within cells and in biological systems containing such cells. In effect, these compositions combine chemical modifications and/or ligand additions with biological functions. The chemical modifications and/or ligand additions provide additional characteristics to the compositions without interfering substantially with their biological function. Such additional characteristics include nuclease resistance, targeting specific cells or specific cell receptors localizing to specific sites within cells and augmenting interactions between the compositions and target cells of interest as well as decreasing such interactions when desired. Also provided by the present invention are processes and kits.
-
Citations
244 Claims
- 1. A non-naturally occurring construct which when present in a cell produces a product, said construct comprising at least one modified nucleotide, a nucleotide analog or a non-nucleic acid entity, or a combination of the foregoing.
- 22. A construct which when present in a cell produces a product, said construct being bound non-ionically to an entity comprising a chemical modification or a ligand.
-
27. A composition comprising:
-
(a) a non-natural entity which comprises;
at least one domain to a nucleic acid component; and
at least one domain to a cell of interest; and
(b) said nucleic acid component;
wherein the domain or domains to said nucleic acid component are different from the domain or domains to said cell. - View Dependent Claims (28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)
-
-
46. A kit for introducing a nucleic acid component into a cell of interest, comprising in packaged containers or combination:
-
(a) a non-natural entity which comprises at least one domain to said nucleic acid component, and a domain to said cell of interest;
(b) a nucleic acid component, optionally with (c) buffers and instructions.
-
-
47. A composition comprising:
-
an entity which comprises at least one domain to a cell of interest, wherein said domain or domains are attached to a nucleic acid component which is in non-double stranded form. - View Dependent Claims (48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63)
-
-
64. A kit for introducing a nucleic acid component into a cell of interest, comprising in packaged containers or combinations:
-
(a) an entity which comprises a domain to said cell of interest, wherein said domain is attached to a nucleic acid component which is in non-double stranded form, optionally with (b) buffers and instructions.
-
-
65. A composition comprising:
-
an entity which comprises a domain to a nucleic acid component, wherein said domain is attached to a cell of interest. - View Dependent Claims (66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81)
-
-
82. A kit for introducing a nucleic acid component into a cell of interest, comprising in packaged containers or combination:
-
(a) an entity which comprises a domain to said nucleic acid component, wherein said domain is attached to said cell of interest, optionally with (b) buffers and instructions.
-
-
83. A multimeric complex composition comprising more than one monomeric unit attached.
(a) to each other through polymeric interactions, or (b) to a binding matrix through polymeric interactions, or (c) both (a) and (b)
- 113. A multimeric composition comprising more than one component attached to a charged polymer, wherein said charged polymer is selected from a polycationic polymer, a polyionic polymer, a polynucleotide, a modified polynucleotide and a polynucleotide analog, or a combination of the foregoing.
- 118. A nucleic acid construct which when introduced into a cell codes for and expresses a non-native polymerase, said polymerase being capable of producing more than one copy of a nucleic acid sequence from said construct.
- 128. A nucleic acid construct which when introduced into a cell produces a nucleic acid product comprising a non-native processing element, which when in a compatible cell, said processing element is substantially removed during processing.
-
134. A process for selectively expressing a nucleic acid product in a cell, which product requires processing for functioning, said process comprising:
-
(i) providing a nucleic acid construct which when introduced into a cell produces a nucleic acid product comprising a non-native processing element, which when in a compatible cell, said processing element is substantially removed during processing; and
(ii) introducing said construct into said cell. - View Dependent Claims (135, 136, 137, 138, 139, 140)
-
- 141. A composition comprising a primary nucleic acid component which upon introduction into a cell produces a secondary nucleic acid component which is capable of producing a nucleic acid product, or a tertiary nucleic acid component, or both, wherein said primary nucleic acid component is not obtained with said secondary or tertiary component or said nucleic acid product.
- 161. A composition of matter comprising a nucleic acid component which when present in a cell produces a non-natural nucleic acid product, which product composes (i) a portion of a localizing localizing entity, and (ii) a nucleic acid sequence of interest.
-
186. A process for localizing a nucleic acid product in a eukaryotic cell, comprising:
-
(a) providing a composition of matter comprising a nucleic acid component which when present in a cell produces a non-natural nucleic acid product, which product comprises;
(i) a portion of a localizing entity, and (ii) a nucleic acid sequence of interest; and
(b) introducing said composition into said cell or into a biological system containing said cell. - View Dependent Claims (187, 188, 189, 190, 191, 192, 193, 194)
-
- 195. A nucleic acid component which upon introduction into a cell is capable of producing more than one specific nucleic acid sequence, each such specific sequence so produced being substantially nonhomologous with each other and being either complementary with a specific portion of a single-stranded nucleic acid of interest in a cell or capable of binding to a specific protein of interest in a cell.
-
210. A process for increasing cellular resistance to a virus of interest, comprising:
-
(a) providing;
(i) transformed cells phenotypically resistant to said virus; and
(ii) a reagent capable of binding to said virus or to a virus-specific site on said cells; and
(b) administering said reagent to a biological system containing said cells to increase the resistance of said cells to the virus of interest. - View Dependent Claims (211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228)
-
-
229. A nucleic acid construct which when introduced into a cell produces a non-natural product, which product comprises two components:
-
(i) a binding component capable of binding to a cellular component; and
(ii) a localization component capable of dislocating said cellular component when bound to said product. - View Dependent Claims (230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243)
-
-
244. A process for dislocating a cellular component in a cell, comprising:
-
(I) providing;
(a) a nucleic acid construct which when introduced into a cell produces a non-natural product, which product comprises two components;
(i) a binding component capable of binding to a cellular component; and
(ii) a localization component capable of dislocating said cellular component when bound to said product; and
(II) introducing said nucleic acid construct into a cell of interest or a biological system containing said cell of interest.
-
Specification